These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 21289519)
21. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis. Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901 [TBL] [Abstract][Full Text] [Related]
22. p73 and p63 regulate the expression of fibroblast growth factor receptor 3. Sayan AE; D'Angelo B; Sayan BS; Tucci P; Cimini A; Cerù MP; Knight RA; Melino G Biochem Biophys Res Commun; 2010 Apr; 394(3):824-8. PubMed ID: 20298673 [TBL] [Abstract][Full Text] [Related]
23. Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC). Wang JL; Wu DW; Cheng ZZ; Han WZ; Xu SW; Sun NN Asian Pac J Cancer Prev; 2014; 15(12):4865-9. PubMed ID: 24998555 [TBL] [Abstract][Full Text] [Related]
24. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma. Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058 [TBL] [Abstract][Full Text] [Related]
25. Expression of p63 and p73 in ameloblastomas. Kumamoto H; Ohki K; Ooya K J Oral Pathol Med; 2005 Apr; 34(4):220-6. PubMed ID: 15752257 [TBL] [Abstract][Full Text] [Related]
26. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck. Boldrup L; Coates PJ; Gu X; Nylander K J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121 [TBL] [Abstract][Full Text] [Related]
27. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer. Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653 [TBL] [Abstract][Full Text] [Related]
28. Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors. Vakonaki E; Soulitzis N; Sifakis S; Papadogianni D; Koutroulakis D; Spandidos DA J Cancer Res Clin Oncol; 2012 Aug; 138(8):1271-8. PubMed ID: 22441934 [TBL] [Abstract][Full Text] [Related]
29. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site. Orzol P; Holcakova J; Nekulova M; Nenutil R; Vojtesek B; Coates PJ Histol Histopathol; 2015 May; 30(5):503-21. PubMed ID: 25510918 [TBL] [Abstract][Full Text] [Related]
30. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo. Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298 [TBL] [Abstract][Full Text] [Related]
32. Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas. Chen YK; Huse SS; Lin LM Int J Exp Pathol; 2004 Apr; 85(2):97-104. PubMed ID: 15154915 [TBL] [Abstract][Full Text] [Related]
33. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Choi HR; Batsakis JG; Zhan F; Sturgis E; Luna MA; El-Naggar AK Hum Pathol; 2002 Feb; 33(2):158-64. PubMed ID: 11957139 [TBL] [Abstract][Full Text] [Related]
34. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis. Geddert H; Kiel S; Heep HJ; Gabbert HE; Sarbia M Hum Pathol; 2003 Sep; 34(9):850-6. PubMed ID: 14562279 [TBL] [Abstract][Full Text] [Related]
35. Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73. Venkatanarayan A; Raulji P; Norton W; Flores ER Cell Cycle; 2016; 15(2):164-71. PubMed ID: 26652033 [TBL] [Abstract][Full Text] [Related]
36. Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis. King KE; Ponnamperuma RM; Gerdes MJ; Tokino T; Yamashita T; Baker CC; Weinberg WC Carcinogenesis; 2006 Jan; 27(1):53-63. PubMed ID: 16081516 [TBL] [Abstract][Full Text] [Related]
37. Expression of the p53 family in lung cancer. Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Nozoe T; Yasumoto K Anticancer Res; 2006; 26(3A):1785-90. PubMed ID: 16827107 [TBL] [Abstract][Full Text] [Related]
38. Alterations of p63 and p73 in human cancers. Inoue K; Fry EA Subcell Biochem; 2014; 85():17-40. PubMed ID: 25201187 [TBL] [Abstract][Full Text] [Related]
39. p63 and p73: roles in development and tumor formation. Moll UM; Slade N Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445 [TBL] [Abstract][Full Text] [Related]
40. p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance. Hong SM; Cho H; Moskaluk CA; Yu E; Zaika AI J Mol Histol; 2007 Jun; 38(3):167-75. PubMed ID: 17385050 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]